Core Laboratories (NYSE:CLB) CEO Lawrence Bruno Acquires 5,000 Shares of Stock

Core Laboratories Inc. (NYSE:CLB) CEO Lawrence Bruno acquired 5,000 shares of the stock in a transaction dated Friday, July 31st. The shares were bought at an average price of $10.78 per share, with a total value of $53,900.00. Following the completion of the transaction, the chief executive officer directly owned 262,438 shares of the company’s stock, valued at $2,829,081.64. The trade was a 1.94% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Core Laboratories Stock Performance

NYSE:CLB opened at $11.24 on Wednesday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.55 and a current ratio of 2.12. Core Laboratories Inc. has a fifty-two week low of $9.72 and a fifty-two week high of $20.36. The company has a 50 day simple moving average of $11.88 and a two-hundred day simple moving average of $15.09. The company has a market capitalization of $515.92 million, a PE ratio of 20.08, a P/E/G ratio of 2.58 and a beta of 1.03.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, July 29th. The oil and gas company reported $0.11 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.02. Core Laboratories had a net margin of 5.10% and a return on equity of 10.03%. The company had revenue of $124.61 million for the quarter, compared to analyst estimates of $126.26 million. During the same period in the prior year, the firm posted $0.19 EPS. The company’s quarterly revenue was down 4.3% on a year-over-year basis. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Research analysts anticipate that Core Laboratories Inc. will post 0.53 earnings per share for the current year.

Core Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, August 31st. Stockholders of record on Monday, August 10th will be given a $0.01 dividend. The ex-dividend date of this dividend is Monday, August 10th. This represents a $0.04 annualized dividend and a dividend yield of 0.4%. Core Laboratories’s dividend payout ratio (DPR) is 7.14%.

Hedge Funds Weigh In On Core Laboratories

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. CWM LLC raised its stake in Core Laboratories by 36.1% during the 4th quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after buying an additional 668 shares during the period. Platinum Investment Management Ltd. grew its stake in Core Laboratories by 3.9% in the third quarter. Platinum Investment Management Ltd. now owns 23,758 shares of the oil and gas company’s stock valued at $294,000 after acquiring an additional 889 shares during the period. The Manufacturers Life Insurance Company increased its holdings in shares of Core Laboratories by 6.2% during the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock valued at $207,000 after acquiring an additional 1,040 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of Core Laboratories by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock valued at $418,000 after acquiring an additional 1,170 shares in the last quarter. Finally, Quarry LP increased its holdings in shares of Core Laboratories by 118.1% during the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock valued at $36,000 after acquiring an additional 1,599 shares in the last quarter. Institutional investors own 97.81% of the company’s stock.

Analyst Ratings Changes

CLB has been the subject of a number of research analyst reports. Weiss Ratings upgraded Core Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday. Wall Street Zen raised shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold”.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.